Ellevest, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Ellevest, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$1.26 - $1.79 $13,478 - $19,147	-10,697 Reduced 38.48%	17,099 $28,000
Q3 2023 Nov 09, 2023	BUY	$1.61 - $2.54 $3,543 - $5,590	2,201 Added 8.6%	27,796 $50,000
Q2 2023 Aug 09, 2023	BUY	$1.14 - $1.95 $21,490 - $36,759	18,851 Added 279.52%	25,595 $47,000
Q1 2023 May 04, 2023	SELL	$1.2 - $2.19 $4,176 - $7,621	-3,480 Reduced 34.04%	6,744 $8,000
Q4 2022 Feb 03, 2023	BUY	$1.63 - $3.52 $7,028 - $15,178	4,312 Added 72.94%	10,224 $17,000
Q3 2022 Nov 02, 2022	BUY	$0.73 - $3.74 $4,315 - $22,110	5,912 New	5,912 $18,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.